It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cutaneous squamous cell carcinoma (SCC) is one of the most common cancers in the United States. Previous genome-wide association studies (GWAS) have identified 14 single nucleotide polymorphisms (SNPs) associated with cutaneous SCC. Here, we report the largest cutaneous SCC meta-analysis to date, representing six international cohorts and totaling 19,149 SCC cases and 680,049 controls. We discover eight novel loci associated with SCC, confirm all previously associated loci, and perform fine mapping of causal variants. The novel SNPs occur within skin-specific regulatory elements and implicate loci involved in cancer development, immune regulation, and keratinocyte differentiation in SCC susceptibility.
The authors perform a meta-analysis of cutaneous squamous cell carcinoma, identifying causal variants within skin-specific regulatory elements.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 Stanford University School of Medicine, Department of Dermatology, Redwood City, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
2 Richard M. Fairbanks School of Public Health, Melvin & Bren Simon Cancer Center, Indiana University, 1050 Wishard Blvd, Department of Epidemiology, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
3 Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
4 deCODE genetics/Amgen Inc., Reykjavik, Iceland (GRID:grid.38142.3c)
5 Erasmus University Medical Center, Department of Dermatology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
6 Erasmus University Medical Center, Department of Internal Medicine, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X)
7 Division of Human Genetics, Comprehensive Cancer Center, Ohio State University, Departments of Cancer Biology and Genetics and Department of Internal Medicine, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
8 Landspitali-University Hospital, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
9 Kaiser Permanente Northern California, Division of Research, Oakland, USA (GRID:grid.280062.e) (ISNI:0000 0000 9957 7758)
10 Stanford University School of Medicine Redwood Bldg, Departments of Epidemiology and Population Health and of Biomedical Data Sciences, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
11 deCODE genetics/Amgen Inc., Reykjavik, Iceland (GRID:grid.38142.3c); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
12 Massachusetts General Hospital, Department of Dermatology, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)